Does AZATHIOPRINE Cause Focal segmental glomerulosclerosis? 16 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Focal segmental glomerulosclerosis have been filed in association with AZATHIOPRINE (AZATHIOPRINE). This represents 0.1% of all adverse event reports for AZATHIOPRINE.
16
Reports of Focal segmental glomerulosclerosis with AZATHIOPRINE
0.1%
of all AZATHIOPRINE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From AZATHIOPRINE?
Of the 16 reports, 3 (18.8%) required hospitalization.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZATHIOPRINE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does AZATHIOPRINE Cause?
Drug ineffective (8,076)
Off label use (5,358)
Drug intolerance (3,392)
Condition aggravated (2,832)
Rheumatoid arthritis (2,746)
Treatment failure (2,483)
Arthralgia (2,427)
Drug hypersensitivity (2,421)
Nausea (2,178)
Pneumonia (2,157)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which AZATHIOPRINE Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
AZATHIOPRINE vs AZD-1222
AZATHIOPRINE vs AZELAIC ACID
AZATHIOPRINE vs AZELASTINE
AZATHIOPRINE vs AZELASTINE\FLUTICASONE
AZATHIOPRINE vs AZELNIDIPINE